ASX Filings

S&P DJI Announces March 2022 Quarterly Rebalance

March 4, 2022

Change in substantial holding

March 3, 2022

Opthea Expands Leadership Team with the Appointment of Joel Naor, M.D., M.Sc., MBA as Chief Medical Officer

March 2, 2022

Opthea Half Year Report and Accounts

February 28, 2022

Change in substantial holding

February 22, 2022

Change in substantial holding

February 21, 2022

Becoming a substantial holder

February 18, 2022

Change in substantial holding

February 16, 2022

Opthea Data for OPT-302 in Patients with Polypoidal Choroidal Vasculopathy (PCV) Presented at Angiogenesis 2022

February 14, 2022

Additional Formats

PDF Version

Angiogenesis 2022 -Prof Cheung presentation of PCV data

February 13, 2022